Concepedia

Sarah Frys

SF

Statistics

Publications

2

Citations

84

H-Index

2

Active since

2015

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Sarah Frys is an author at Roswell Park Comprehensive Cancer Center specializing in molecular oncology, rituximab-based therapy, and medicine.

Publications per year

2015–2015

2

Publications

2

Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents

Sarah Frys, Zachary Simons, Qiang Hu et al. · British Journal of Haematology · 2015 · 48 citations · Full text

, , +13

Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo

Natalie M Czuczman, Matthew J. Barth, Juan Gu et al. · Blood · 2015 · 36 citations · Full text

, , +8

1–2 of 2